NIH-funded research R01 grant

How weight-loss surgery improves heart and metabolic health

Official title: Defining the pathways of cardiometabolic health after weight loss

Funded at Columbia University Health Sciences · NIH-11248848 · Data updated 2026-11-12

This research looks at biological changes after Roux-en-Y gastric bypass to understand how the surgery helps adults with obesity reduce diabetes and heart disease risk.

More Weight Loss research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2024
Project endDecember 31, 2028
Funding year2026
Award (this year)$694,979
NIH project number5R01DK136134-03
Project IDNIH-11248848 on NIH RePORTER

Who could benefit from this research

Could help

Adults with obesity, particularly those considering or who have had Roux-en-Y gastric bypass or who have type 2 diabetes or high cardiovascular risk, would be the ideal candidates.

Less likely to help

People without obesity or those not undergoing weight-loss surgery are unlikely to get direct benefit from this specific research.

What this research studies

If you have obesity and are considering or have had weight-loss surgery, this project follows people who undergo Roux-en-Y gastric bypass to see what biological changes happen after the operation. Researchers will collect samples such as blood and stool and measure hormones, bile acids, metabolites, gut tissue signals, and the microbiome over time to link those changes to improvements in diabetes and heart risk. They will compare patterns across people to find common pathways that might explain why some patients get larger, longer-lasting benefits than others. Findings could point to tests that predict outcomes or to new treatments that reproduce the surgery's benefits without an operation.

Why it matters

Potential benefit: Could identify biological signals that predict who benefits most from surgery and reveal targets for new therapies to lower diabetes and cardiovascular risk.

How similar studies have gone: Prior work shows bariatric surgery often improves diabetes and heart risk and has linked changes in hormones, bile acids, and the microbiome, but mapping the full set of pathways in humans remains incomplete.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Thaker, Vidhu V. — Columbia University Health Sciences
  • Study coordinator: Thaker, Vidhu V.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.